Aeroflex Industries has informed the stock exchanges of an upcoming virtual meeting with investors and analysts, scheduled for May 19, 2026. The intimation was filed on May 11, 2026, in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

The company's officials will interact with investors and analysts in a group meeting format. The key details of the scheduled interaction are as follows:

Scope of Discussion

Aeroflex Industries has clarified that all discussions during the meeting will be based on publicly available information. The company has explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interaction. The company has also noted that changes to the schedule may occur due to exigencies on the part of the participants or the company.

The intimation was signed by Ruthu Parampogi, Company Secretary & Compliance Officer (Membership No.: A60982), on behalf of Aeroflex Industries Limited.

Aeroflex Industries Limited has filed its Statement of Deviation and Variation under Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter and year ended March 31, 2026. The filing, dated May 05, 2026, was submitted to both BSE Limited and the National Stock Exchange of India Limited. The statement was reviewed by the Audit Committee and subsequently taken on record by the Board of Directors.

Fund Raising Details

The company raised funds through the allotment of equity shares on a preferential basis, with the date of allotment recorded as February 03, 2026. The total amount raised stood at Rs. 54,99,99,714.60. The filing confirms that there is no deviation or variation in the utilisation of these funds against the originally disclosed objects. No monitoring agency was applicable for this fund raise.

The following table summarises the key parameters of the fund raising as disclosed in the filing:

Fund Utilisation Breakdown

The total funds raised have been allocated across specific objects as originally disclosed. The table below presents the original allocation, funds utilised during the period, and the deviation status for each object (amounts in Rs.):

No modified objects or modified allocations were reported against any of the above categories. The company confirmed that all preferential issue expenses, including advisory fees of Rs. 1,41,60,000.00 and board meetings, extraordinary general meetings, and miscellaneous expenses of Rs. 3,40,000.00, have been fully utilised as originally allocated.

Regulatory Compliance

The filing was signed by Ruthu Parampogi, Company Secretary & Compliance Officer (M. No. A60982), on May 05, 2026. As per the disclosure, deviation or variation under Regulation 32 may encompass deviation in the objects or purposes for which funds were raised, deviation in the amount actually utilised against original disclosures, or changes in terms of a contract referred to in the fund-raising document. Aeroflex Industries confirmed that none of these conditions apply to the current reporting period.